<?xml version='1.0' encoding='utf-8'?>
<document id="12463729"><sentence text="Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together."><entity charOffset="42-53" id="DDI-PubMed.12463729.s1.e0" text="galantamine" /><entity charOffset="58-69" id="DDI-PubMed.12463729.s1.e1" text="risperidone" /><pair ddi="false" e1="DDI-PubMed.12463729.s1.e0" e2="DDI-PubMed.12463729.s1.e0" /><pair ddi="false" e1="DDI-PubMed.12463729.s1.e0" e2="DDI-PubMed.12463729.s1.e1" /></sentence><sentence text="To explore the steady-state pharmacokinetic profile after coadministration of galantamine and risperidone, an open-label, randomized, single-center, two-way crossover drug-drug interaction study was conducted in 16 healthy elderly subjects, ages 60 years and older"><entity charOffset="78-89" id="DDI-PubMed.12463729.s2.e0" text="galantamine" /><entity charOffset="94-105" id="DDI-PubMed.12463729.s2.e1" text="risperidone" /><pair ddi="false" e1="DDI-PubMed.12463729.s2.e0" e2="DDI-PubMed.12463729.s2.e0" /><pair ddi="false" e1="DDI-PubMed.12463729.s2.e0" e2="DDI-PubMed.12463729.s2.e1" /></sentence><sentence text=" The results showed that risperidone, when administered with galantamine, did not change the bioavailability of galantamine at steady state"><entity charOffset="25-36" id="DDI-PubMed.12463729.s3.e0" text="risperidone" /><entity charOffset="61-72" id="DDI-PubMed.12463729.s3.e1" text="galantamine" /><entity charOffset="112-123" id="DDI-PubMed.12463729.s3.e2" text="galantamine" /><pair ddi="false" e1="DDI-PubMed.12463729.s3.e0" e2="DDI-PubMed.12463729.s3.e0" /><pair ddi="false" e1="DDI-PubMed.12463729.s3.e0" e2="DDI-PubMed.12463729.s3.e1" /><pair ddi="false" e1="DDI-PubMed.12463729.s3.e0" e2="DDI-PubMed.12463729.s3.e2" /><pair ddi="false" e1="DDI-PubMed.12463729.s3.e1" e2="DDI-PubMed.12463729.s3.e1" /><pair ddi="false" e1="DDI-PubMed.12463729.s3.e1" e2="DDI-PubMed.12463729.s3.e2" /></sentence><sentence text=" In addition, systemic exposure of risperidone active moiety (risperidone plus 9-hydroxyrisperidone), the most clinically relevant component of risperidone treatment, was not affected by galantamine coadministration, while systemic exposure was increased by approximately 10% for risperidone and decreased by about 10% for 9-hydroxyrisperidone (active metabolite of risperidone)"><entity charOffset="35-46" id="DDI-PubMed.12463729.s4.e0" text="risperidone" /><entity charOffset="62-73" id="DDI-PubMed.12463729.s4.e1" text="risperidone" /><entity charOffset="79-99" id="DDI-PubMed.12463729.s4.e2" text="9-hydroxyrisperidone" /><entity charOffset="144-155" id="DDI-PubMed.12463729.s4.e3" text="risperidone" /><entity charOffset="187-198" id="DDI-PubMed.12463729.s4.e4" text="galantamine" /><entity charOffset="280-291" id="DDI-PubMed.12463729.s4.e5" text="risperidone" /><entity charOffset="323-343" id="DDI-PubMed.12463729.s4.e6" text="9-hydroxyrisperidone" /><entity charOffset="366-377" id="DDI-PubMed.12463729.s4.e7" text="risperidone" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e0" e2="DDI-PubMed.12463729.s4.e0" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e0" e2="DDI-PubMed.12463729.s4.e1" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e0" e2="DDI-PubMed.12463729.s4.e2" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e0" e2="DDI-PubMed.12463729.s4.e3" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e0" e2="DDI-PubMed.12463729.s4.e4" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e0" e2="DDI-PubMed.12463729.s4.e5" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e0" e2="DDI-PubMed.12463729.s4.e6" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e0" e2="DDI-PubMed.12463729.s4.e7" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e1" e2="DDI-PubMed.12463729.s4.e1" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e1" e2="DDI-PubMed.12463729.s4.e2" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e1" e2="DDI-PubMed.12463729.s4.e3" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e1" e2="DDI-PubMed.12463729.s4.e4" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e1" e2="DDI-PubMed.12463729.s4.e5" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e1" e2="DDI-PubMed.12463729.s4.e6" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e1" e2="DDI-PubMed.12463729.s4.e7" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e2" e2="DDI-PubMed.12463729.s4.e2" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e2" e2="DDI-PubMed.12463729.s4.e3" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e2" e2="DDI-PubMed.12463729.s4.e4" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e2" e2="DDI-PubMed.12463729.s4.e5" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e2" e2="DDI-PubMed.12463729.s4.e6" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e2" e2="DDI-PubMed.12463729.s4.e7" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e3" e2="DDI-PubMed.12463729.s4.e3" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e3" e2="DDI-PubMed.12463729.s4.e4" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e3" e2="DDI-PubMed.12463729.s4.e5" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e3" e2="DDI-PubMed.12463729.s4.e6" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e3" e2="DDI-PubMed.12463729.s4.e7" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e4" e2="DDI-PubMed.12463729.s4.e4" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e4" e2="DDI-PubMed.12463729.s4.e5" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e4" e2="DDI-PubMed.12463729.s4.e6" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e4" e2="DDI-PubMed.12463729.s4.e7" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e5" e2="DDI-PubMed.12463729.s4.e5" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e5" e2="DDI-PubMed.12463729.s4.e6" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e5" e2="DDI-PubMed.12463729.s4.e7" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e6" e2="DDI-PubMed.12463729.s4.e6" /><pair ddi="false" e1="DDI-PubMed.12463729.s4.e6" e2="DDI-PubMed.12463729.s4.e7" /></sentence><sentence text=" Galantamine and risperidone were both safe and well tolerated administered either alone or together"><entity charOffset="1-12" id="DDI-PubMed.12463729.s5.e0" text="Galantamine" /><entity charOffset="17-28" id="DDI-PubMed.12463729.s5.e1" text="risperidone" /><pair ddi="false" e1="DDI-PubMed.12463729.s5.e0" e2="DDI-PubMed.12463729.s5.e0" /><pair ddi="false" e1="DDI-PubMed.12463729.s5.e0" e2="DDI-PubMed.12463729.s5.e1" /></sentence><sentence text=" Thus, no dose adjustment for either risperidone orgalantamine is necessary when these two drugs are administered together in the dose range evaluated"><entity charOffset="37-62" id="DDI-PubMed.12463729.s6.e0" text="risperidone orgalantamine" /></sentence><sentence text="" /></document>